BridgeMD
New treatment option for Hematologic Malignancy
Official title Home Blood Transfusions
ClinicalTrials.gov ID: NCT07121140
What this study is testing
- What it's testing
- This is a pilot single arm study to evaluate the feasibility and acceptability of a home blood transfusion program. Patients will be enrolled with hematologic malignancies and other bone marrow failure syndromes who are transfusion dependent and interested in a home blood transfusion program.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Individuals must meet all of the following in order to be eligible to participate in the study:
- Provide signed and dated informed consent form Willing to comply with all study procedures and be available for the duration of the study
- Male or female, over the age of 18
- Must meet definition of transfusion dependence (require at least 2 blood product transfusions over a 28-day period)
- Receive their cancer care at SKCCC
You likely can't join if
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Patients who have a history of a transfusion reaction
- Heart failure as defined by AHA stage C or NYHA Class II-IV
- Non-English or Spanish speaking
- Are unhoused
- Are incarcerated
See the full eligibility criteria
- Individuals must meet all of the following in order to be eligible to participate in the study:
- Provide signed and dated informed consent form Willing to comply with all study procedures and be available for the duration of the study
- Male or female, over the age of 18
- Must meet definition of transfusion dependence (require at least 2 blood product transfusions over a 28-day period)
- Receive their cancer care at SKCCC
- Have a history of blood product transfusions and NO history of transfusion reactions,
- Live within a 30-mile range of the Center City SKCCC location.
- Must be willing to allow people into the home
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Patients who have a history of a transfusion reaction
- Heart failure as defined by AHA stage C or NYHA Class II-IV
- Non-English or Spanish speaking
- Are unhoused
- Are incarcerated
- Have poor venous access
- Diagnosis of Solid Tumor malignancy
- Women who are pregnant
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.